Mounjaro is a subcutaneous (under-the-skin) injection taken once weekly to regulate or reduce weight, treat type 2 diabetes, or both
BPC 157 was studied almost exclusively by the same Croatian team that created it, doing rat study after rat study, while MK-677 was the domain of the Merck Research Laboratories in New Jersey, whose scientists conducted multiple small trials in humans in the 1990s, trying to see if the drug had interesting effects on a variety of surrogate markers
The Yale study found that only about half the sites' questionnaires covered eating disorder history, 39% asked when the patient last had a medical evaluation and 8% skipped contraindications entirely (personal or family history factors that could mean a GLP-1 may not be safe for that person)
This was a randomized, double-blind, placebo-controlled trial
Staying hydrated and eating smaller meals can also help minimize discomfort
If you do drink, do so with food, slowly, and in moderation and never on an empty stomach